Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19

Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19 Publisher Pubmed

Alizadehsani R¹ ; Eskandarian R² ; Behjati M³ ; Zahmatkesh M² ; Roshanzamir M⁴ ; Izadi NH⁵ ; Shoeibi A^{6, 7} ; Haddadi A⁸ ; Khozeimeh F¹ ; Sani FA⁹ ; Sani ZA¹⁰ ; Roshanzamir Z¹¹ ; Khosravi A¹ ; Nahavandi S¹ Show All Authors

Alizadehsani R¹
Eskandarian R²
Behjati M³
Zahmatkesh M²
Roshanzamir M⁴
Izadi NH⁵
Shoeibi A^{6, 7}
Haddadi A⁸
Khozeimeh F¹
Sani FA⁹
Sani ZA¹⁰
Roshanzamir Z¹¹
Khosravi A¹
Nahavandi S¹
Sarrafzadegan N^{12, 13}
Islam SMS^{14, 15, 16}

Show Affiliations

1. Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Geelong, Australia
2. Internal Medicine Research Center, Semnan University of Medical Sciences, Semnan, Iran
3. Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
4. Department of Engineering, Fasa University, Fars, Fasa, Iran
5. Department of Electrical and Computer Engineering, Isfahan University of Technology, Isfahan, Iran
6. Computer Engineering Department, Ferdowsi University of Mashhad, Mashhad, Iran
7. Faculty of Electrical and Computer Engineering, Biomedical Data Acquisition Lab, K. N. Toosi University of Technology, Tehran, Iran
8. Department of Biology, Faculy of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
9. Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran
10. Department of Cardiac MRI, Omid Hospital, Tehran, Iran
11. Pediatric Respiratory and Sleep Medicine Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
12. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
13. Faculty of Medicine, SPPH, University of British Columbia, Vancouver, BC, Canada
14. Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC, Australia
15. Cardiovascular Division, The George Institute for Global Health, Newtown, Australia
16. Sydney Medical School, University of Sydney, Camperdown, Australia

Source: Immunity# Inflammation and Disease Published:2022

Abstract

Introduction: To reduce mortality in hospitalized patients with COVID-19 and cardiovascular disease (CVD), it is necessary to understand the relationship between patient's symptoms, risk factors, and comorbidities with their mortality rate. To the best of our knowledge, this paper is the first which take into account the determinants like risk factors, symptoms, and comorbidities leading to mortality in CVD patients who are hospitalized with COVID-19. Methods: This study was conducted on 660 hospitalized patients with CVD and COVID-19 recruited between January 2020 and January 2021 in Iran. All patients were diagnosed with the previous history of CVD like angina, myocardial infarction, heart failure, cardiomyopathy, abnormal heart rhythms, and congenital heart disease before they were hospitalized for COVID-19. We collected data on patient's signs and symptoms, clinical and paraclinical examinations, and any underlying comorbidities. t test was used to determine the significant difference between the two deceased and alive groups. In addition, the relation between pairs of symptoms and pairs of comorbidities has been determined via correlation computation. Results: Our findings suggest that signs and symptoms such as fever, cough, myalgia, chest pain, chills, abdominal pain, nausea, vomiting, diarrhea, and anorexia had no impact on patients' mortality. There was a significant correlation between COVID-19 cardiovascular patients' mortality rate and symptoms such as headache, loss of consciousness (LOC), oxygen saturation less than 93%, and need for mechanical ventilation. Conclusions: Our results might help physicians identify early symptoms, comorbidities, and risk factors related to mortality in CVD patients hospitalized for COVID-19. © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Related Docs

View other Related Docs

1. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)

2. Metabolic Syndrome and Covid-19; Clinical Complications and Challenges, Journal of Isfahan Medical School (2021)

3. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)

4. Risk Factors Prediction, Clinical Outcomes, and Mortality In Covid-19 Patients, Journal of Medical Virology (2021)

5. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)

6. Covid-19 Mortality and Its Predictors in the Elderly: A Systematic Review, Health Science Reports (2022)

7. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)

8. Clinical Characteristics and Outcomes of Diabetics Hospitalized for Covid-19 Infection: A Single-Centered, Retrospective, Observational Study, EXCLI Journal (2020)

Experts (# of related papers)

View all Related Experts

Seyed Ahmad Seyed Alinaghi (3)

Majid Sorouri (2)

Style	Citing Format
MLA	Alizadehsani R, et al.. "Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19." Immunity# Inflammation and Disease, vol. 10, no. 3, 2022, pp. -.
APA	Alizadehsani R, Eskandarian R, Behjati M, Zahmatkesh M, Roshanzamir M, Izadi NH, Shoeibi A, Haddadi A, Khozeimeh F, Sani FA, Sani ZA, Roshanzamir Z, Khosravi A, Nahavandi S, Sarrafzadegan N, Islam SMS (2022). Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19. Immunity# Inflammation and Disease, 10(3), -.
Chicago	Alizadehsani R, Eskandarian R, Behjati M, Zahmatkesh M, Roshanzamir M, Izadi NH, Shoeibi A, et al.. "Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19." Immunity# Inflammation and Disease 10, no. 3 (2022): -.
Harvard	Alizadehsani R et al. (2022) 'Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19', Immunity# Inflammation and Disease, 10(3), pp. -.
Vancouver	Alizadehsani R, Eskandarian R, Behjati M, Zahmatkesh M, Roshanzamir M, Izadi NH, et al.. Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19. Immunity# Inflammation and Disease. 2022;10(3):-.
BibTex	@article{ author = {Alizadehsani R and Eskandarian R and Behjati M and Zahmatkesh M and Roshanzamir M and Izadi NH and Shoeibi A and Haddadi A and Khozeimeh F and Sani FA and Sani ZA and Roshanzamir Z and Khosravi A and Nahavandi S and Sarrafzadegan N and Islam SMS}, title = {Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19}, journal = {Immunity# Inflammation and Disease}, volume = {10}, number = {3}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Alizadehsani R AU - Eskandarian R AU - Behjati M AU - Zahmatkesh M AU - Roshanzamir M AU - Izadi NH AU - Shoeibi A AU - Haddadi A AU - Khozeimeh F AU - Sani FA AU - Sani ZA AU - Roshanzamir Z AU - Khosravi A AU - Nahavandi S AU - Sarrafzadegan N AU - Islam SMS TI - Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19 JO - Immunity# Inflammation and Disease VL - 10 IS - 3 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract